Guilbaud, Emma
Galluzzi, Lorenzo http://orcid.org/0000-0003-2257-8500
Article History
First Online: 26 September 2022
Competing interests
: L.G. is/has been holding research contracts with Lytix Biopharma, Promontory and Onxeo, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options.